FdaApplication
ANDA 203959
Identifiers
- fda_app_no: ANDA203959
Properties
| Property | Value |
|---|---|
| applicant_name | WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2017-04-18 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TEMOZOLOMIDE | TEMOZOLOMIDE | 140MG | CAPSULE;ORAL |
| TEMOZOLOMIDE | TEMOZOLOMIDE | 250MG | CAPSULE;ORAL |
| TEMOZOLOMIDE | TEMOZOLOMIDE | 5MG | CAPSULE;ORAL |
| TEMOZOLOMIDE | TEMOZOLOMIDE | 100MG | CAPSULE;ORAL |
| TEMOZOLOMIDE | TEMOZOLOMIDE | 20MG | CAPSULE;ORAL |
5 products